These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

220 related items for PubMed ID: 7548597

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Multicentre study on antibiotic susceptibilities of anaerobic bacteria to cefoperazone-sulbactam and other antimicrobial agents.
    Clark RB, Bartelt MA, Chan EL, Dalton HP.
    J Antimicrob Chemother; 1992 Jan; 29(1):57-67. PubMed ID: 1737725
    [Abstract] [Full Text] [Related]

  • 5. Comparative susceptibility of the Bacteroides fragilis group species and other anaerobic bacteria to meropenem, imipenem, piperacillin, cefoxitin, ampicillin/sulbactam, clindamycin and metronidazole.
    Goldstein EJ, Citron DM, Cherubin CE, Hillier SL.
    J Antimicrob Chemother; 1993 Mar; 31(3):363-72. PubMed ID: 8486570
    [Abstract] [Full Text] [Related]

  • 6. Susceptibilities of anaerobic gram-negative bacilli to thirteen antimicrobials and beta-lactamase inhibitor combinations.
    Hill GB, Ayers OM, Everett BQ.
    J Antimicrob Chemother; 1991 Dec; 28(6):855-67. PubMed ID: 1816182
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro activity of amoxycillin/clavulanate and ticarcillin/clavulanate compared with that of other antibiotics against anaerobic bacteria: comparison with the results of the 1987 survey.
    Pierard D, De Meyer A, Rosseel P, Van Cauwenbergh M, Struelens MJ, Delmee M, Goossens H, Claeys G, Glupczynski Y, Verbist L, Melin P, Lauwers S.
    Acta Clin Belg; 1996 Dec; 51(2):70-9. PubMed ID: 8693871
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro activity of cefoperazone plus sulbactam compared with that of other antimicrobial agents against anaerobic bacteria.
    Wexler HM, Finegold SM.
    Antimicrob Agents Chemother; 1988 Mar; 32(3):403-6. PubMed ID: 3364960
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS, Tosin I, Sejas L, Miranda E.
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [Abstract] [Full Text] [Related]

  • 13. Antimicrobial susceptibility of anaerobic bacteria in Bulgaria.
    Marina M, Ivanova M, Kantardjiev T.
    Anaerobe; 2009 Aug; 15(4):127-32. PubMed ID: 19292999
    [Abstract] [Full Text] [Related]

  • 14. Effect of bovine lactoferrin on the MICs of ampicillin/sulbactam (UNASYN), amoxicillin/clavulanic acid (Augmentin), ticarcillin clavulanate (Timentin), and piperacillin-tazobactam (ZOSYN), against clinical and environmental isolates of motile Aeromonas.
    WaKabongo M, Stucki ZN, Torbert DP, Olweny J.
    J Am Osteopath Assoc; 2005 Jan; 105(1):25-6. PubMed ID: 15710671
    [No Abstract] [Full Text] [Related]

  • 15. A multicenter international study on the activity of sulbactam/ampicillin, ampicillin, and cefoxitin against anaerobic bacteria and introduction of a new model of susceptibility testing in mixed infections.
    Heizmann WR, Heilmann F, Werner H.
    Suppl Int J Gynecol Obstet; 1989 Jan; 2():7-12; discussion 47-8. PubMed ID: 2679683
    [Abstract] [Full Text] [Related]

  • 16. [The effect of a combination of ampicillin and sulbactam against clinical anaerobic isolates].
    Werner H, Heizmann W, Heilmann F.
    Arzneimittelforschung; 1988 Jul; 38(7):866-8. PubMed ID: 3207432
    [Abstract] [Full Text] [Related]

  • 17. In vitro activity of ampicillin plus sulbactam against anaerobes compared to ampicillin and cefoxitin.
    Heizmann W, Heilmann F, Werner H.
    Infection; 1987 Jul; 15(5):370-4. PubMed ID: 3692611
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Inhibitory and bactericidal activity of selected beta-lactam agents alone and in combination with beta-lactamase inhibitors compared with that of cefoxitin and metronidazole against cefoxitin-susceptible and cefoxitin-resistant isolates of the Bacteroides fragilis group.
    Stratton CW, Weeks LS, Aldridge KE.
    Diagn Microbiol Infect Dis; 1992 Jul; 15(4):321-30. PubMed ID: 1611847
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.